Publikationen
Suche in 13066 Publikationen:
13066 Publikation(en)
[Molecularly-targeted anticancer treatments - a short appraisal]
Jörger M. [Molecularly-targeted anticancer treatments - a short appraisal]. Ther Umsch 2019; 76:179-185.
01.09.2019[Molecularly-targeted anticancer treatments - a short appraisal]
01.09.2019Ther Umsch 2019; 76:179-185
Jörger Markus
End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
Buchauer K, Socoliuctoquant A, Plasswilm L, Schiefer J (2019). End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques.
31.08.2019End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
31.08.2019SASRO 2019
Buchauer Konrad, Socoliuctoquant A, Plasswilm Ludwig, Schiefer Johann
Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review
Fulchini R, Albrich W, Kronenberg A, Egli A, Kahlert C, Schlegel M, Kohler P. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review. Epidemiol Infect 2019; 147:e259.
30.08.2019Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review
30.08.2019Epidemiol Infect 2019; 147:e259
Fulchini R, Albrich Werner, Kronenberg A, Egli A, Kahlert Christian, Schlegel Matthias, Kohler Philipp
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
Jörger M, Sessa C, Stuedeli S, Levy N, Hafner P, Lane H, Larger P, Engelhardt M, Kaindl T, Volden M, Mark M, Mantiero M, Hess D, Metaxas Y, Stathis A, von Moos R. A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors. Invest New Drugs 2019
30.08.2019A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
30.08.2019Invest New Drugs 2019
Jörger Markus, Sessa Cristiana, Stuedeli Silvia, Levy Nicole, Hafner Peter, Lane Heidi, Larger Patrice, Engelhardt Marc, Kaindl Thomas, Volden Matthias, Mark Michael, Mantiero Mara, Hess Dagmar, Metaxas Yannis, Stathis Anastasios, von Moos Roger
Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature.
Roethlisberger M, Jayapalan R, Hostettler I, Bin Abd Kadir K, Mun K, Brand Y, Mariani L, Prepageran N, Waran V. Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature. World Neurosurg 2019; 133:381-391.e2.
30.08.2019Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature.
30.08.2019World Neurosurg 2019; 133:381-391.e2
Roethlisberger Michel, Jayapalan Ronie Romelean, Hostettler Isabel, Bin Abd Kadir Khairul Azmi, Mun Kein Seong, Brand Yves, Mariani Luigi, Prepageran Narayanan, Waran Vicknes
Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends
Stienen M, Schaller K, Regli L, Ringel F, Demetriades A, Schubert G, Adib S, Samprón N, Renovanz M, Moojen W, Krieg S, Kolias A, Freyschlag C, Czabanka M, Bartek J, Meling T. Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends. Acta Neurochir (Wien) 2019; 161:1977-1979.
29.08.2019Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends
29.08.2019Acta Neurochir (Wien) 2019; 161:1977-1979
Stienen Martin N., Schaller Karl, Regli Luca, Ringel Florian, Demetriades Andreas K, Schubert Gerrit A, Adib Sasan D, Samprón Nicolás, Renovanz Mirjam, Moojen Wouter, Krieg Sandro M, Kolias Angelos, Freyschlag Christian F, Czabanka Marcus A, Bartek Jiri, Meling Torstein R
Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum
Messerli-Odermatt O, Serrallach B, Gubser M, Leschka S, Bauer R, Dubois J, Alkadhi H, Wildermuth S, Wälti S. Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum. Acad Radiol 2019; 27:644-650.
28.08.2019Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum
28.08.2019Acad Radiol 2019; 27:644-650
Messerli-Odermatt Olivia, Serrallach Bettina, Gubser Manuel, Leschka Sebastian, Bauer Ralf, Dubois Josée, Alkadhi Hatem, Wildermuth Simon, Wälti Stephan
Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score
Lairez O, Hauck C, Paolini C, Bilato C, Prasad A, Rihal C, Liu K, Schulze P, Bianco M, Jörg L, Rickli H, Carrilho-Ferreira P, Poglajen G, El-Battrawy I, Akin I, Gilyarova E, Shilova A, Gilyarov M, Kozel M, Tousek P, Winchester D, Galuszka J, Ukena C, Nguyen T, Kobayashi Y, Böhm M, Bauersachs J, Katus H, Horowitz J, di Mario C, Münzel T, Crea F, Bax J, Lüscher T, Ruschitzka F, Ghadri J, Thiele H, Schunkert H, Maier L, Pinto F, Widimsky P, Borggrefe M, Felix S, Opolski G, Braun-Dullaeus R, Rottbauer W, Hasenfuß G, Pieske B, Templin C, Delmas C, Wischnewsky M, Sorici-Barb I, Jaguszewski M, Noutsias M, Knorr M, Heiner S, Burgdorf C, Kherad B, Tschope C, Sarcon A, Shinbane J, Franke J, Neuhaus M, Candreva A, Bacchi B, Cammann V, Kato K, Szawan K, Gili S, D'Ascenzo F, Dichtl W, Citro R, Bossone E, Rajan L, Michels G, Pfister R, Airaksinen K, Napp L, Budnik M, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Chan C, Bridgman P, Vasankari T, Fischer T, Cuneo A, Jacobshagen C, Karakas M, Koenig W, Pott A, Meyer P, Arroja J, Banning A, Cuculi F, Kobza R, Beug D. Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score. Eur J Heart Fail 2019; 21:1469-1472.
27.08.2019Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score
27.08.2019Eur J Heart Fail 2019; 21:1469-1472
Lairez Olivier, Hauck Christian, Paolini Carla, Bilato Claudio, Prasad Abhiram, Rihal Charanjit S, Liu Kan, Schulze P Christian, Bianco Matteo, Jörg Lucas, Rickli Hans, Carrilho-Ferreira Pedro, Poglajen Gregor, El-Battrawy Ibrahim, Akin Ibrahim, Gilyarova Ekaterina, Shilova Alexandra, Gilyarov Mikhail, Kozel Martin, Tousek Petr, Winchester David E, Galuszka Jan, Ukena Christian, Nguyen Thanh H, Kobayashi Yoshio, Böhm Michael, Bauersachs Johann, Katus Hugo A, Horowitz John, di Mario Carlo, Münzel Thomas, Crea Filippo, Bax Jeroen J, Lüscher Thomas F, Ruschitzka Frank, Ghadri Jelena R, Thiele Holger, Schunkert Heribert, Maier Lars S, Pinto Fausto J, Widimsky Petr, Borggrefe Martin, Felix Stephan B, Opolski Grzegorz, Braun-Dullaeus Ruediger C, Rottbauer Wolfgang, Hasenfuß Gerd, Pieske Burkert M, Templin Christian, Delmas Clément, Wischnewsky Manfred B, Sorici-Barb Ioana, Jaguszewski Milosz, Noutsias Michel, Knorr Maike, Heiner Susanne, Burgdorf Christof, Kherad Behrouz, Tschope Carsten, Sarcon Annahita, Shinbane Jerold, Franke Jennifer, Neuhaus Michael, Candreva Alessandro, Bacchi Beatrice, Cammann Victoria L, Kato Ken, Szawan Konrad A, Gili Sebastiano, D'Ascenzo Fabrizio, Dichtl Wolfgang, Citro Rodolfo, Bossone Eduardo, Rajan Lawrence, Michels Guido, Pfister Roman, Airaksinen K E Juhani, Napp L Christian, Budnik Monika, Dworakowski Rafal, MacCarthy Philip, Kaiser Christoph, Osswald Stefan, Galiuto Leonarda, Chan Christina, Bridgman Paul, Vasankari Tuija, Fischer Thomas A, Cuneo Alessandro, Jacobshagen Claudius, Karakas Mahir, Koenig Wolfgang, Pott Alexander, Meyer Philippe, Arroja Jose David, Banning Adrian, Cuculi Florim, Kobza Richard, Beug Daniel
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Hitz F, Driessen C, Mey U, Samaras P, Vilei S, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle T, Besse L, Hess D, Pabst T, Kraus M, Swiss Group for Clinical Cancer Research SAKK. Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood Cancer J 2019; 9:70.
27.08.2019Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
27.08.2019Blood Cancer J 2019; 9:70
Hitz Felicitas, Driessen Christoph, Mey U, Samaras P, Vilei S Berardi, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle Tobias, Besse Lenka, Hess Dagmar, Pabst T, Kraus Marianne, Swiss Group for Clinical Cancer Research SAKK
Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol
Kocher A, Simon M, Dwyer A, Villiger P, Künzler-Heule P, De Geest S, Berben L, Nicca D. Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol. J Adv Nurs 2019
26.08.2019Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol
26.08.2019J Adv Nurs 2019
Kocher Agnes, Simon Michael, Dwyer Andrew A, Villiger Peter M, Künzler-Heule Patrizia, De Geest Sabina, Berben Lut, Nicca Dunja
Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24
Sze L, Tschopp O, Neidert M, Bernays R, Ghirlanda C, Zwimpfer C, Wiesli P, Schmid C. Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24. Growth Horm IGF Res 2019; 51:77.
26.08.2019Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24
26.08.2019Growth Horm IGF Res 2019; 51:77
Sze Lisa, Tschopp Oliver, Neidert Marian Christoph, Bernays René L, Ghirlanda Claudia, Zwimpfer Cornelia, Wiesli Peter, Schmid Christoph
Is it really IBS? Ovarian carcinoma
Hornung R (2019). Is it really IBS? Ovarian carcinoma. Präsentiert bei: 2nd Neuro Gastro Day Switzerland - The Neuro Gastro Motility Network (Swiss NGM), Universitätsspital Zürich
24.08.2019Is it really IBS? Ovarian carcinoma
24.08.20192nd Neuro Gastro Day Switzerland - The Neuro Gastro Motility Network (Swiss NGM)
Hornung René
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Hoyle A, Aebersold D, Jones R, Matheson D, Millman R, Mason M, Ritchie A, Russell M, Douis H, Parmar M, Sydes M, Clarke N, Gillessen Sommer S, Ingleby F, Ali A, James N, Cook A, Parker C, de Bono J, Attard G, Chowdhury S, Cross W, Dearnaley D, Brawley C, Gilson C, STAMPEDE Investigators. Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. Eur Urol 2019; 76:719-728.
23.08.2019Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
23.08.2019Eur Urol 2019; 76:719-728
Hoyle Alex P, Aebersold Daniel M, Jones Rob J, Matheson David, Millman Robin, Mason Malcolm D, Ritchie Alastair W S, Russell Martin, Douis Hassan, Parmar Mahesh K B, Sydes Matthew R, Clarke Noel W, Gillessen Sommer Silke, Ingleby Fiona, Ali Adnan, James Nicholas D, Cook Adrian, Parker Christopher C, de Bono Johann S, Attard Gerhardt, Chowdhury Simon, Cross William R, Dearnaley David P, Brawley Christopher D, Gilson Clare, STAMPEDE Investigators
Sexualität bei Krebserkrankungen
Siercks I (2019). Sexualität bei Krebserkrankungen. Präsentiert bei: Nachdiplomstudium Onkologiepflege 2019, St. Gallen
23.08.2019Sexualität bei Krebserkrankungen
23.08.2019Nachdiplomstudium Onkologiepflege 2019
Siercks Ikbale
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Hasan Ali O, Sadik C, Zillikens D, Schmidt E, Jochum W, Mani B, Cozzio A, Braun A, Emtenani S, Hammers C, Abdou M, Diem S, Fässler M, Berner F, Ring S, Bomze D, Flatz L. BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. J Am Acad Dermatol 2019; 82:854-861.
23.08.2019BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
23.08.2019J Am Acad Dermatol 2019; 82:854-861
Hasan Ali Omar, Sadik Christian D, Zillikens Detlef, Schmidt Enno, Jochum Wolfram, Mani Bernhard, Cozzio Antonio, Braun Anne, Emtenani Shirin, Hammers Christoph, Abdou Marie-Therese, Diem Stefan, Fässler Mirjam, Berner Fiamma, Ring Sandra S, Bomze David, Flatz Lukas
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Kratochwil C, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester H, Bodei L, Fanti S, Haberkorn U, Kopka K, Konijnenberg M, Kabasakal L, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Herrmann K. EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2019; 46:2536-2544.
22.08.2019EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
22.08.2019Eur J Nucl Med Mol Imaging 2019; 46:2536-2544
Kratochwil Clemens, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Kopka Klaus, Konijnenberg Mark, Kabasakal Levant, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Herrmann Ken
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
Bomze D, Hasan Ali O, Bate A, Flatz L. Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden. JAMA Oncol 2019
22.08.2019Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
22.08.2019JAMA Oncol 2019
Bomze David, Hasan Ali Omar, Bate Andrew, Flatz Lukas
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
Hartmann S, Hansmann M, Engert A, Rosenwald A, Möller P, Klapper W, Stein H, Quintanilla-Martinez L, Fend F, Cogliatti S, Ott G, Feller A, Bernd H, Mottok A, Plütschow A, Eichenauer D. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol 2019; 94:1208-1213.
21.08.2019The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
21.08.2019Am J Hematol 2019; 94:1208-1213
Hartmann Sylvia, Hansmann Martin-Leo, Engert Andreas, Rosenwald Andreas, Möller Peter, Klapper Wolfram, Stein Harald, Quintanilla-Martinez Leticia, Fend Falko, Cogliatti Sergio B., Ott German, Feller Alfred C, Bernd Heinz-Wolfram, Mottok Anja, Plütschow Annette, Eichenauer Dennis A
Building a Global Alliance in Vascular Surgery
White J, Conte M, Bradbury A, Kolh P, Dick F, Fitridge R, Mills J, Ricco J, Suresh K. Building a Global Alliance in Vascular Surgery. Eur J Vasc Endovasc Surg 2019; 58:318-319.
21.08.2019Building a Global Alliance in Vascular Surgery
21.08.2019Eur J Vasc Endovasc Surg 2019; 58:318-319
White John, Conte Michael, Bradbury Andrew, Kolh Philippe, Dick Florian, Fitridge Robert, Mills Joseph, Ricco Jean-Baptiste, Suresh Kal
Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair
Guber J, Bentivoglio M, Scholl H, Sturm V, Valmaggia C. Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair. Clin Ophthalmol. 2019:1587-1591.
21.08.2019Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair
21.08.2019Clin Ophthalmol. 2019:1587-1591
Guber Josef, Bentivoglio Maico, Scholl Hendrik P. N., Sturm Veit, Valmaggia Christophe